Gunanusa Eramandiri Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Gunanusa Eramandiri Tbk. trades at Rp220 (market cap 550B, 73.5K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Gunanusa Eramandiri Tbk. is far larger — about 3.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (324K versus 73.5K). Which is the better fit depends on your goals.
| GUNA | OBAT | |
|---|---|---|
Market Cap | 550B | 166.01B |
Volume | 73.5K | 324K |
Lot | 735 | 3.24K |
Turnover | 15.97M | 77.68M |
Average Price | 217.24 | 239.75 |
Value | 15.97M | 77.68M |
Indicative Equilibrium Price | 220 | 240 |
Indicative Equilibrium Volume | 10 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Gunanusa Eramandiri Tbk (the Company) was established based on Notarial deed of Lasma Batubara, S.H., No. 60 dated August 5, 1993. The Company started its commercial operation in August 1993.
Read more on GUNA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →